Webinar

An Introduction to Strawberry Creek Ventures

Strawberry Creek Ventures Managing Partner Matt Caspari

Join us for a 45-minute presentation about Strawberry Creek Ventures, Alumni Ventures’ UC Berkeley-focused venture capital fund. The discussion is led by Strawberry Creek Ventures’ Managing Partner Matt Caspari and is open to all alumni and friends of UC Berkeley.

Sorry we missed you!

This event has already occurred. If you attended the webinar, please check your inbox for a recording. If you were unable to attend but wish to learn more about Strawberry Creek Ventures please book a call with one of our Senior Partners or register for an upcoming webinar.

And in the meantime, learn more about Strawberry Creek Ventures Managing Partner, Matt Caspari, by watching the video below:

See video policy below.

During the session, we will discuss:

  • Home

    The goal and structure of the fund
  • Home

    The value of the Alumni Ventures' mode
  • Home

    Some examples of current portfolio companies
  • Home

    Benefits of diversifying into venture capital
  • Home

    Minimum requirements needed to invest in the fund
  • Home

    You must be accredited to invest in venture capital

Note: You must be accredited to invest in venture capital. Important disclosure information can be found at av-funds.com/disclosures

About your presenter

Matt Caspari
Matt Caspari

Managing Partner, Strawberry Creek Ventures

Overview

Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.

Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.

Funds actively worked on

Investment Area of Focus

His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.

Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).

Learn How To Invest In Companies In This Sector With Alumni Ventures:
Deep Tech Fund>>>

Webinar Registration